This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: University of California, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022-2024
Title: Gopika G Nair: Innovator in Diabetes Research
Introduction
Gopika G Nair is a prominent inventor based in San Francisco, CA, known for her significant contributions to diabetes research. She holds two patents that focus on innovative methods for treating diabetes mellitus and advancing the field of regenerative medicine.
Latest Patents
Her latest patents include "Preservation of pancreatic islet grafts in the extrahepatic space," which outlines methods and compositions for treating diabetes through the co-transplantation of insulin-producing cells and cells derived from parathyroid glands. Another notable patent is "Production of fully functional mature beta cells from human pancreatic progenitors," which provides methods for the effective differentiation of embryonic stem cells into mature beta cells that can secrete insulin in response to glucose levels. These advancements are crucial for developing transplant therapeutics for diabetic individuals and for drug screening purposes.
Career Highlights
Gopika has worked with esteemed institutions such as the University of California and the United States Government, represented by the Department of Veterans Affairs. Her work has been instrumental in pushing the boundaries of diabetes treatment and research.
Collaborations
Throughout her career, Gopika has collaborated with notable professionals in her field, including Matthias Hebrok and Casey Ward. These partnerships have enhanced her research and contributed to her innovative approaches in diabetes care.
Conclusion
Gopika G Nair's work exemplifies the intersection of innovation and healthcare, particularly in the realm of diabetes treatment. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile